查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
核酸样品制备市场 - 2018-2028年全球行业规模、份额、趋势、竞争、机会及预测（按产品、技术、治疗领域、应用、终端用户、地区和竞争划分
市场调查报告书
商品编码
1309864

核酸样品制备市场 - 2018-2028年全球行业规模、份额、趋势、竞争、机会及预测（按产品、技术、治疗领域、应用、终端用户、地区和竞争划分

Nucleic Acid Sample Preparation Market- Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Technology, By Therapeutic Area, By Application, By End Users,By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在 2024-2028 年的预测期内，核酸样品制备市场的复合年增长率预计将达到惊人的水平。这主要归因于核酸分子在各种治疗领域的应用日益广泛等因素。

生命科学领域的研发不断增长

政府、学术界和机构等为扩大生命科学研究而增加的投资预计将推动核酸样品制备市场的需求。例如，2022 年 2 月，Brightlamp 公司和普渡大学附属 Amplified Sciences LLC 公司分别从普渡大学铸造投资基金获得了约 25 万美元的研发资助，以推动生命科学的发展。Amplifies Sciences 正在研究用于癌症和其他疾病预诊断的先进技术。同样，Brightlamp 也是一家利用机器学习和计算机视觉来加强和改善医疗保健的公司。

核酸在治疗领域的应用不断增长

随着对及时诊断疾病的需求不断增长，以及在一些患者治疗过程中对诊断信息的需求，开发出了不同的分子程序，从而增加了核酸样本提取以跟进诊断程序，预计这将为核酸样本制备市场带来丰厚的需求。此外，癌症等慢性疾病的发病率不断上升，增加了分子水平诊断的需求，因此核酸样本提取和制备需求的增加推动了预测期内的市场增长。此外，样本制备也是精准医疗中的一项重要应用，因为它能确保安全水平并成功使用定制疗法。

对核酸提取系统的需求不断增长

核酸分离/提取是分子诊断或任何分子实验室研究中最基本的步骤，随着用于提取样本的各种设备和方法的出现，这一领域也在不断扩大。自动核酸提取系统的出现促进了核酸样品制备市场的增长。此外，自动化程度的提高还能以最小的误差率同时运行多个样本，还能从血清、组织、细胞培养等不同样本中提取核酸，因此有望加速核酸样本制备市场的发展。例如，2020 年 2 月，市场参与者 Covaris 公司推出了两款新型试剂盒，用于利用喉咙或鼻拭子采集装置提取病毒 RNA，其中包括 truXTRAC-PCR 直接病毒 RNA 提取试剂盒和 truXTRAC 病毒 RNA 提取试剂盒。

下一代测序需求增长（下游应用）

疾病中对下一代测序（NGS）需求的增加推动了核酸样品制备市场的需求。基因或靶向序列携带着感兴趣的基因或疾病载体，因此可被识别并用于疾病诊断。此外，靶向测序允许研究人员针对特定的兴趣基因、编码区甚至染色体片段进行测序，使其成为一种有用的测序技术，以收集准确、快速和精确的数据。在预测期内，用于测序程序的试剂盒和开发试剂的可用性将支持市场的增长并促进核酸样品制备市场的发展。

最新动态

主要市场参与者正在推出新产品并扩大其产品组合。例如，2020 年 2 月，Miroculus 公司推出了新型系统 Miro Canvas，该系统可将复杂的方案（如巢代测序文库制备）自动化、简单化和微型化。

可定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。本报告提供以下定制选项：

公司信息

  • 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 市场覆盖范围
    • 研究年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目标
  • 基准方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概述
  • 主要市场细分概述
  • 主要市场参与者概述
  • 主要地区/国家概述
  • 市场驱动因素、挑战和趋势概述

第 4 章 : 临床试验分析

  • 正在进行的临床试验
  • 已完成的临床试验
  • 终止的临床试验
  • 按开发阶段分類的管线细分
  • 按状态分類的管线
  • 按研究类型分類的管线细分
  • 按地区划分
  • 临床试验热图

第 5 章：客户之声

第6章：核酸样品制备市场展望

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 按产品（耗材、系统和附件及组件）
    • 按技术（旋转柱技术、磁珠技术及其他）
    • 按治疗领域（肿瘤学、传染病、人类遗传学/群体遗传学及其他）
    • 按应用（基因组学、蛋白质组学及其他）
    • 按最终用户（学术和研究机构、制药和生物技术公司、临床和诊断实验室及其他）
    • 按公司（2022 年）
    • 按地区
  • 产品市场图

第 7 章 ：亚太地区核酸样品制备市场展望

  • 市场规模与预测
    • 按价值
  • 市场份额及预测
    • 产品
    • 技术
    • 治疗领域
    • 应用领域
    • 终端用户
    • 按国家
  • 亚太地区：国家分析
    • 中国 .
    • 印度 .
    • 印度 .
    • 日本
    • 澳大利亚

第 8 章 : 欧洲核酸样品制备市场前景

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 产品
    • 技术
    • 治疗领域
    • 应用领域
    • 终端用户
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 9 章：北美腐殖基生物刺激剂市场前景。

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 产品
    • 技术
    • 治疗领域
    • 应用领域
    • 终端用户
    • 按国家
  • 北美洲：国家分析
    • 美国核酸样品制备市场前景
      • 市场规模与预测
        • 按价值
      • 市场份额与预测
        • 产品
        • 技术
        • 治疗领域
        • 应用领域
        • 终端用户
    • 墨西哥核酸样品制备市场前景
      • 市场规模与预测
        • 按价值
      • 市场份额与预测
        • 产品
        • 技术
        • 治疗领域
        • 应用领域
        • 终端用户
    • 加拿大核酸样品制备市场前景
      • 市场规模与预测
        • 按价值
      • 市场份额与预测
        • 产品
        • 技术
        • 治疗领域
        • 应用领域
        • 最终用户

第 10 章 : 南美核酸样品制备市场前景

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 产品
    • 技术
    • 治疗领域
    • 应用领域
    • 终端用户
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 11 章 ：中东和非洲核酸样品制备市场展望

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 产品
    • 技术
    • 治疗领域
    • 应用领域
    • 终端用户
    • 按国家
  • 中东和非洲：国家分析
    • 南非 核酸样品制备
    • 沙特阿拉伯核酸样品制备
    • 阿联酋 核酸样品制备
    • 科威特核酸样品制备

第 12 章 ：市场动态

  • 驱动因素
  • 挑战

第 13 章 ：市场趋势与发展

  • 近期动态
  • 合併与收购
  • 产品开发

第14章：竞争格局

  • 业务概述
  • 公司概况
  • 产品与服务
  • 财务状况（上市公司）
  • 近期发展
  • SWOT 分析
    • BGI Group (MGI Tech Co., Ltd.)
    • F. Hoffmann-La Roche Ltd
    • Danaher. (Beckman Coulter, Inc.)
    • Eppendorf SE
    • Bioneer Corporation
    • Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • Merck KGaA
    • Norgen Biotek Corp
    • Aurora Biomed Inc.
    • Agilent Technologies, Inc

第 15 章：战略建议

简介目录
Product Code: 14942

Nucleic Acid Sample Preparation Market is expected to register an impressive CAGR during the forecast period of 2024-2028. This can be attributed to factors such as the growing usage of nucleic acid molecules in various therapeutic areas.

Moreover, other factors, such as growing advancement in nucleic acid extraction and isolation techniques and growing demand for downstream applications such as Next Generation Sequencing (NGS), targeted sequencing, etc., drive the growth of the Nucleic Acid Sample Preparation market.

Growing Research & Development in Life Sciences

Increasing investment by the government, academics & institutions, etc., to expand research in life science is expected to drive the market demand for the Nucleic Acid Sample Preparation market. For instance, in February 2022, Brightlamp Inc. and Purdue-affiliated Amplified Sciences LLC received a grant of approximately US$ 250,000 each from the Purdue Foundry Investment Fund for R&D to bring advancement in life sciences. The Amplifies Sciences is researching advancing technology for pre-diagnosis of cancer and other diseases. Similarly, Brightlamp is a company that utilizes machine learning and computer vision to enhance and improve healthcare.

Growing Usage of Nucleic Acid in Therapeutic Areas

With the growing demand for disease diagnosis on time and the need for diagnostic information in several patient treatments, distinct molecular procedures are developed and thus are increasing the nucleic acid sample extraction to follow the diagnosis procedures and is anticipated to offer lucrative demand to the nucleic acid sample preparation market. Moreover, the growing prevalence of chronic diseases such as cancer is increasing the need for diagnosis at the molecular level, and thus increase in demand for nucleic acid sample extraction and preparation is driving the market growth during the forecast period. Moreover, sample preparation is an essential application in precision medicine on account of its safety assurance level and successful use of tailored therapies.

Growing Demand for Nucleic Acid Extraction Systems

Nucleic acid isolation /extraction is the most basic step involved in molecular diagnosis or any molecular laboratory research and is expanding with the availability of a distinct range of equipment and methods used for the extraction of samples. The availability of automated nucleic acid extraction systems is bolstering the market growth for the nucleic acid sample preparation market. Moreover, increased automation has leads to running multiple samples at the same time with minimum error ratio and also can extract nucleic acid from distinct samples, such as serum and tissue, cell culture and thus is expected to accelerate the Nucleic Acid Sample Preparation Market. For instance, in February 2020, the market player Covaris Inc. introduced two new kits for viral RNA extraction with throat or nasal swab collection devices, which include the truXTRAC-PCR Direct viral RNA Extraction kit and truXTRAC Viral RNA Extraction kit.

Growing demand for Next generation Sequencing (Downstream applications)

The increased demand for Next-generation Sequencing (NGS) in disease is propelling the demand for the Nucleic Acid Sample Preparation market. The gene or targeted sequence carries a gene or interest or a disease carrier and thus can be identified and used in disease diagnosing. Additionally, targeted sequencing allows researchers to target particular genes of interest, coding areas, and even chromosomal segments, making it a useful technique for sequencing in order to collect accurate, quick, and precise data. The availability of kits and developed reagents for sequencing procedures is attributed to support the market growth and bolster the Nucleic Acid Sample Preparation market during the forecast period.

Recent Developments

Key market players are introducing their new products and expanding their product portfolio. For instance, in February 2020, Miroculus Inc. introduced its Miro Canvas -a new system that can automate, simplify and miniaturize complex protocols like nest generation sequencing library preparation.

Market Segmentation

The Nucleic Acid Sample Preparation Market is segmented based on product, technology, therapeutic area, application, end users, and region. Based on product, the market is further segmented into consumables, systems, and accessories & components. Based on technology, the market is further segmented into spin-column-based technology, magnetic-bead-based technology, and others. Based on Therapeutic Area, the market is segmented into oncology, infectious disease, human genetics/population genetics, and others. Based on application, the market is further segmented into genomics, proteomics, and others. Based on end users, the market is further segmented into end users (academic and research institutions, pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

BGI Group (MGI Tech Co., Ltd.), F. Hoffmann-La Roche Ltd, Danaher. (Beckman Coulter, Inc.), Eppendorf SE, Bioneer Corporation, Endress+Hauser Group Services AG (Analytik Jena GmbH), Merck KGaA, Norgen Biotek Corp, Aurora Biomed Inc., Agilent Technologies, Inc., are some of the major players operating in the global nucleic acid sample preparation Market.

Report Scope

In this report, Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Nucleic Acid Sample Preparation, By Product:

  • Consumables
  • Systems
  • Accessories & Components

Nucleic Acid Sample Preparation, By Technology:

  • Spin-Column-Based Technology
  • Magnetic-Bead Based Technology
  • Others

Nucleic Acid Sample Preparation, By Therapeutic Area:

  • Oncology
  • Infectious Disease
  • Human Genetics/Population Genetics
  • Others

Nucleic Acid Sample Preparation, By Application:

  • Genomics
  • Proteomics
  • Others

Nucleic Acid Sample Preparation, By End Users:

  • Academic and Research Institutions
  • Pharmaceutical
  • Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Other

Nucleic Acid Sample Preparation, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Nucleic Acid Sample Preparation market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Clinical Trial Analysis

  • 4.1. Ongoing Clinical Trials
  • 4.2. Completed Clinical Trials
  • 4.3. Terminated Clinical Trials
  • 4.4. Breakdown of Pipeline, By Development Phase
  • 4.5. Breakdown of Pipeline, By Status
  • 4.6. Breakdown of Pipeline, By Study Type
  • 4.7. Breakdown of Pipeline, By Region
  • 4.8. Clinical Trials Heat Map

5. Voice of Customer

6. Nucleic Acid Sample Preparation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables, Systems and Accessories & Components)
    • 6.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology and Others)
    • 6.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
    • 6.2.4. By Application (Genomics, Proteomics and Others)
    • 6.2.5. By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories and Other)
    • 6.2.6. By Company (2022)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Product
    • 7.2.2. Technology
    • 7.2.3. Therapeutic Area
    • 7.2.4. Application
    • 7.2.5. End Users
    • 7.2.6. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Nucleic Acid Sample Preparation Market Outlook.
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Product
        • 7.3.1.2.2. Technology
        • 7.3.1.2.3. Therapeutic Area
        • 7.3.1.2.4. Application
        • 7.3.1.2.5. End Users
    • 7.3.2. India Nucleic Acid Sample Preparation Market Outlook.
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Product
        • 7.3.2.2.2. Technology
        • 7.3.2.2.3. Therapeutic Area
        • 7.3.2.2.4. Application
        • 7.3.2.2.5. End Users
    • 7.3.3. South Korea Nucleic Acid Sample Preparation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Product
        • 7.3.3.2.2. Technology
        • 7.3.3.2.3. Therapeutic Area
        • 7.3.3.2.4. Application
        • 7.3.3.2.5. End Users
    • 7.3.4. Japan Nucleic Acid Sample Preparation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Product
        • 7.3.4.2.2. Technology
        • 7.3.4.2.3. Therapeutic Area
        • 7.3.4.2.4. Application
        • 7.3.4.2.5. End Users
    • 7.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Product
        • 7.3.5.2.2. Technology
        • 7.3.5.2.3. Therapeutic Area
        • 7.3.5.2.4. Application
        • 7.3.5.2.5. End Users

8. Europe Nucleic Acid Sample Preparation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Product
    • 8.2.2. Technology
    • 8.2.3. Therapeutic Area
    • 8.2.4. Application
    • 8.2.5. End Users
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Nucleic Acid Sample Preparation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Product
        • 8.3.1.2.2. Technology
        • 8.3.1.2.3. Therapeutic Area
        • 8.3.1.2.4. Application
        • 8.3.1.2.5. End Users
    • 8.3.2. Germany Nucleic Acid Sample Preparation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Product
        • 8.3.2.2.2. Technology
        • 8.3.2.2.3. Therapeutic Area
        • 8.3.2.2.4. Application
        • 8.3.2.2.5. End Users
    • 8.3.3. United Kingdom Nucleic Acid Sample Preparation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Product
        • 8.3.3.2.2. Technology
        • 8.3.3.2.3. Therapeutic Area
        • 8.3.3.2.4. Application
        • 8.3.3.2.5. End Users
    • 8.3.4. Italy Nucleic Acid Sample Preparation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. Product
        • 8.3.4.2.2. Technology
        • 8.3.4.2.3. Therapeutic Area
        • 8.3.4.2.4. Application
        • 8.3.4.2.5. End Users
    • 8.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. Product
        • 8.3.5.2.2. Technology
        • 8.3.5.2.3. Therapeutic Area
        • 8.3.5.2.4. Application
        • 8.3.5.2.5. End Users

9. North America Humic-based bio stimulants Market Outlook.

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Product
    • 9.2.2. Technology
    • 9.2.3. Therapeutic Area
    • 9.2.4. Application
    • 9.2.5. End Users
    • 9.2.6. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Nucleic Acid Sample Preparation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Product
        • 9.3.1.2.2. Technology
        • 9.3.1.2.3. Therapeutic Area
        • 9.3.1.2.4. Application
        • 9.3.1.2.5. End Users
    • 9.3.2. Mexico Nucleic Acid Sample Preparation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Product
        • 9.3.2.2.2. Technology
        • 9.3.2.2.3. Therapeutic Area
        • 9.3.2.2.4. Application
        • 9.3.2.2.5. End Users
    • 9.3.3. Canada Nucleic Acid Sample Preparation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Product
        • 9.3.3.2.2. Technology
        • 9.3.3.2.3. Therapeutic Area
        • 9.3.3.2.4. Application
        • 9.3.3.2.5. End Users

10. South America Nucleic Acid Sample Preparation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Product
    • 10.2.2. Technology
    • 10.2.3. Therapeutic Area
    • 10.2.4. Application
    • 10.2.5. End Users
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Product
        • 10.3.1.2.2. Technology
        • 10.3.1.2.3. Therapeutic Area
        • 10.3.1.2.4. Application
        • 10.3.1.2.5. End Users
    • 10.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Product
        • 10.3.2.2.2. Technology
        • 10.3.2.2.3. Therapeutic Area
        • 10.3.2.2.4. Application
        • 10.3.2.2.5. End Users
    • 10.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Product
        • 10.3.3.2.2. Technology
        • 10.3.3.2.3. Therapeutic Area
        • 10.3.3.2.4. Application
        • 10.3.3.2.5. End Users

11. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. Product
    • 11.2.2. Technology
    • 11.2.3. Therapeutic Area
    • 11.2.4. Application
    • 11.2.5. End Users
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. Product
        • 11.3.1.2.2. Technology
        • 11.3.1.2.3. Therapeutic Area
        • 11.3.1.2.4. Application
        • 11.3.1.2.5. End Users
    • 11.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. Product
        • 11.3.2.2.2. Technology
        • 11.3.2.2.3. Therapeutic Area
        • 11.3.2.2.4. Application
        • 11.3.2.2.5. End Users
    • 11.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. Product
        • 11.3.3.2.2. Technology
        • 11.3.3.2.3. Therapeutic Area
        • 11.3.3.2.4. Application
        • 11.3.3.2.5. End Users
    • 11.3.4. Kuwait Nucleic Acid Sample Preparation Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. Product
        • 11.3.4.2.2. Technology
        • 11.3.4.2.3. Therapeutic Area
        • 11.3.4.2.4. Application
        • 11.3.4.2.5. End Users

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Developments

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (In case of listed companies)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. BGI Group (MGI Tech Co., Ltd.)
    • 14.6.2. F. Hoffmann-La Roche Ltd
    • 14.6.3. Danaher. (Beckman Coulter, Inc.)
    • 14.6.4. Eppendorf SE
    • 14.6.5. Bioneer Corporation
    • 14.6.6. Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • 14.6.7. Merck KGaA
    • 14.6.8. Norgen Biotek Corp
    • 14.6.9. Aurora Biomed Inc.
    • 14.6.10. Agilent Technologies, Inc

15. Strategic Recommendations